Subdued Growth No Barrier To Sam Chun Dang Pharm. Co., Ltd With Shares Advancing 44 percent - Simply Wall St

009300 Stock  KRW 17,310  240.00  1.37%   
About 61% of Sam A's investor base is looking to short. The analysis of current outlook of investing in Sam A Pharm Co suggests that many traders are alarmed regarding Sam A's prospects. The current market sentiment, together with Sam A's historical and current headlines, can help investors time the market. In addition, many technical investors use Sam A Pharm stock news signals to limit their universe of possible portfolio assets.
  
Subdued Growth No Barrier To Sam Chun Dang Pharm. Co., Ltd With Shares Advancing 44 Simply Wall St

Read at news.google.com
Google News at Macroaxis
  

Sam A Fundamental Analysis

We analyze Sam A's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sam A using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sam A based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Return On Asset

Return On Asset Comparative Analysis

Sam A is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Sam A Pharm Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sam A stock to make a market-neutral strategy. Peer analysis of Sam A could also be used in its relative valuation, which is a method of valuing Sam A by comparing valuation metrics with similar companies.

Complementary Tools for Sam Stock analysis

When running Sam A's price analysis, check to measure Sam A's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sam A is operating at the current time. Most of Sam A's value examination focuses on studying past and present price action to predict the probability of Sam A's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sam A's price. Additionally, you may evaluate how the addition of Sam A to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies